Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma I: Introduction01:28

Asthma I: Introduction

88
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Allergic Reactions02:06

Allergic Reactions

26.3K
Overview
26.3K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

277
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
277
Antibody Structure01:10

Antibody Structure

51.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
51.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
Same author

Melittin in AllergoOncology: From Honey Bee Venom to Anti-Cancer Therapeutic Innovation-An EAACI Position Paper.

Allergy·2026
Same author

Meaningful outcomes in food allergy immunotherapy: Measuring what counts.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Chronic rhinosinusitis with nasal polyps (CRSwNP) through an epigenetic lens: Plasmacytoma variant translocation 1 (PVT1) as a potential biomarker and therapeutic target.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Mast Cells in Acute COVID-19 Patients.

Allergy·2026
Same author

Restoration of Keratinocyte Homeostasis Drives Resolution of Skin Inflammation.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Apr 27, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
16:01

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

Published on: January 26, 2015

11.8K

Eosinophils interaction with mast cells: the allergic effector unit.

Roopesh Singh Gangwar1, Francesca Levi-Schaffer

  • 1Department of Pharmacology and Experimental Therapeutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, 12065, Jerusalem, 91120, Israel.

Methods in Molecular Biology (Clifton, N.J.)
|July 3, 2014
PubMed
Summary

Mast cells and eosinophils are key in allergic reactions, interacting bidirectionally through cell contact and mediators. This "Allergic Effector Unit" interaction can be studied in vitro using co-cultured cells.

More Related Videos

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.3K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
16:01

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

Published on: January 26, 2015

11.8K
An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.3K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K

Area of Science:

  • Immunology
  • Allergy Research

Background:

  • Mast cells (MC) and eosinophils are central effector cells in allergic responses.
  • Allergic reactions involve distinct early and late phases.
  • MC and eosinophils interact bidirectionally in inflamed tissues during late and chronic allergic phases.

Purpose of the Study:

  • To investigate the bidirectional crosstalk between mast cells and eosinophils.
  • To understand the mechanisms mediating mast cell-eosinophil interactions in allergic inflammation.
  • To establish an in vitro model for studying the "Allergic Effector Unit" (AEU).

Main Methods:

  • Utilizing a customized co-culture system.
  • Employing both mouse and human-derived mast cells and eosinophils.
  • Analyzing cell-cell contact via receptors (e.g., CD48, 2B4) and soluble mediators (cytokines, chemokines).

Main Results:

  • Demonstrated bidirectional communication between mast cells and eosinophils.
  • Identified physical cell-cell contacts and soluble mediators as key interaction pathways.
  • Characterized the combined MC-eosinophil unit as the "Allergic Effector Unit" (AEU).

Conclusions:

  • Mast cell-eosinophil interactions are crucial in allergic inflammation.
  • The AEU, involving physical and soluble mediator crosstalk, drives allergic responses.
  • In vitro co-culture systems provide a viable model to study these complex interactions.